Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 1
2004 8
2005 11
2006 12
2007 13
2008 33
2009 35
2010 30
2011 37
2012 63
2013 65
2014 97
2015 111
2016 148
2017 164
2018 200
2019 196
2020 272
2021 335
2022 343
2023 302
2024 92

Text availability

Article attribute

Article type

Publication date

Search Results

2,185 results

Results by year

Filters applied: . Clear all
Page 1
Impact of physical exercise in patients with chronic kidney disease: Sistematic review and meta-analysis.
Villanego F, Naranjo J, Vigara LA, Cazorla JM, Montero ME, García T, Torrado J, Mazuecos A. Villanego F, et al. Nefrologia (Engl Ed). 2020 May-Jun;40(3):237-252. doi: 10.1016/j.nefro.2020.01.002. Epub 2020 Apr 15. Nefrologia (Engl Ed). 2020. PMID: 32305232 Free article. English, Spanish.
Physical exercise may offer multiple benefits to patients with chronic kidney disease (CKD). However, it was not traditionally recommended because of the possibility of impairing renal function and increasing proteinuria. The objective of this study is to review the …
Physical exercise may offer multiple benefits to patients with chronic kidney disease (CKD). However, it was not traditionally …
Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis.
Al Khalaf S, Bodunde E, Maher GM, O'Reilly ÉJ, McCarthy FP, O'Shaughnessy MM, O'Neill SM, Khashan AS. Al Khalaf S, et al. Am J Obstet Gynecol. 2022 May;226(5):656-670.e32. doi: 10.1016/j.ajog.2021.10.037. Epub 2021 Nov 2. Am J Obstet Gynecol. 2022. PMID: 34736915 Review.
OBJECTIVE: Limited evidence exists on the role that the cause of chronic kidney disease plays in determining pregnancy outcomes. The aim of this systematic review and meta-analysis was to examine the association between chronic kidney disease and adver …
OBJECTIVE: Limited evidence exists on the role that the cause of chronic kidney disease plays in determining pregnancy outcome …
Insulin resistance in chronic kidney disease: a systematic review.
Spoto B, Pisano A, Zoccali C. Spoto B, et al. Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1087-F1108. doi: 10.1152/ajprenal.00340.2016. Epub 2016 Oct 5. Am J Physiol Renal Physiol. 2016. PMID: 27707707 Free article. Review.
Insulin resistance (IR) is an early metabolic alteration in chronic kidney disease (CKD) patients, being apparent when the glomerular filtration rate is still within the normal range and becoming almost universal in those who reach the end stage of kidney failure. . …
Insulin resistance (IR) is an early metabolic alteration in chronic kidney disease (CKD) patients, being apparent when the glo …
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials.
Garcia Sanchez JJ, Thompson J, Scott DA, Evans R, Rao N, Sörstadius E, James G, Nolan S, Wittbrodt ET, Abdul Sultan A, Stefansson BV, Jackson D, Abrams KR. Garcia Sanchez JJ, et al. Adv Ther. 2022 Jan;39(1):193-220. doi: 10.1007/s12325-021-02006-z. Epub 2021 Dec 8. Adv Ther. 2022. PMID: 34881414 Free PMC article. Review.
Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD). New drug classes to augment renin-angiotensin-aldosterone system (RAAS) inhibitors as the standard of care have scarcely met their primary …
Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD) …
Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Inzucchi SE, et al. JAMA. 2014 Dec 24-31;312(24):2668-75. doi: 10.1001/jama.2014.15298. JAMA. 2014. PMID: 25536258 Free PMC article. Review.
EVIDENCE ACQUISITION: In July 2014, we searched the MEDLINE and Cochrane databases for English-language articles pertaining to metformin, kidney disease, and lactic acidosis in humans between 1950 and June 2014. ...Data suggesting an increased risk of lactic acidosi …
EVIDENCE ACQUISITION: In July 2014, we searched the MEDLINE and Cochrane databases for English-language articles pertaining to metformin, …
Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis.
Chuasuwan A, Pooripussarakul S, Thakkinstian A, Ingsathit A, Pattanaprateep O. Chuasuwan A, et al. Health Qual Life Outcomes. 2020 Jun 18;18(1):191. doi: 10.1186/s12955-020-01449-2. Health Qual Life Outcomes. 2020. PMID: 32552800 Free PMC article.
The pooled USMD of KDQOL were 9.67 (5.67, 13.68), 6.71 (- 5.92, 19.32) 6.30 (- 0.41, 12.18), 2.35 (- 4.35, 9.04), 2.10 (0.07, 4.13), and 1.21 (- 2.98, 5.40) for burden of kidney disease, work status, effects of kidney disease, quality of social interac …
The pooled USMD of KDQOL were 9.67 (5.67, 13.68), 6.71 (- 5.92, 19.32) 6.30 (- 0.41, 12.18), 2.35 (- 4.35, 9.04), 2.10 (0.07, 4.13), and 1.2 …
Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review.
Murton M, Goff-Leggett D, Bobrowska A, Garcia Sanchez JJ, James G, Wittbrodt E, Nolan S, Sörstadius E, Pecoits-Filho R, Tuttle K. Murton M, et al. Adv Ther. 2021 Jan;38(1):180-200. doi: 10.1007/s12325-020-01568-8. Epub 2020 Nov 24. Adv Ther. 2021. PMID: 33231861 Free PMC article. Review.
INTRODUCTION: The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 guidelines recommend classifying patients by glomerular filtration rate (GFR) and albuminuria to predict chronic kidney disease (CKD) prognosis. ...
INTRODUCTION: The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 guidelines recommend classifying patients by glomerul …
Exercise interventions for improving objective physical function in patients with end-stage kidney disease on dialysis: a systematic review and meta-analysis.
Clarkson MJ, Bennett PN, Fraser SF, Warmington SA. Clarkson MJ, et al. Am J Physiol Renal Physiol. 2019 May 1;316(5):F856-F872. doi: 10.1152/ajprenal.00317.2018. Epub 2019 Feb 13. Am J Physiol Renal Physiol. 2019. PMID: 30759022 Free article.
Patients with end-stage kidney disease on dialysis have increased mortality and reduced physical activity, contributing to impaired physical function. ...From the evidence available, exercise, regardless of modality, improved objective measures of physical function …
Patients with end-stage kidney disease on dialysis have increased mortality and reduced physical activity, contributing to imp …
Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY, Chen LR, Chen KH. Hsu CY, et al. Int J Mol Sci. 2020 Sep 18;21(18):6846. doi: 10.3390/ijms21186846. Int J Mol Sci. 2020. PMID: 32961953 Free PMC article.
Chronic kidney disease (CKD) is associated with the development of mineral bone disorder (MBD), osteoporosis, and fragility fractures. ...
Chronic kidney disease (CKD) is associated with the development of mineral bone disorder (MBD), osteoporosis, and fragility fr …
Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
Cao H, Rao X, Jia J, Yan T, Li D. Cao H, et al. Acta Diabetol. 2023 Mar;60(3):325-335. doi: 10.1007/s00592-022-01989-7. Epub 2022 Nov 1. Acta Diabetol. 2023. PMID: 36316605 Review.
AIMS: The overall effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors in patients with advanced chronic kidney disease (CKD) (estimated glomerular filtration rate (eGFR), 15-30 ml/min per 1.73 m(2)) remain unclear, and we thus conducted a systematic review …
AIMS: The overall effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors in patients with advanced chronic kidney disease …
2,185 results